Appeals Court Supports Patent Board Flexibility In Ethicon Case
This article was originally published in The Gray Sheet
Executive Summary
Ethicon argued that a US Patent and Trademark Board policy allowing the same panel to decide whether to accept a patent challenge for review and issue a final ruling on its validity violates due process. A split Federal Circuit panel disagreed and supported the patent board’s finding that Ethicon’s surgical staple patent is invalid.
You may also be interested in...
High Court Won’t Hear Covidien Patent Appeal
The company had asked the Supreme Court to hear arguments to restore a $176 million patent infringement judgment against Ethicon. A lower court voided the award because Ethicon developed a prototype before Covidien’s patents were filed.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.